A KCR1 variant implicated in susceptibility to the long QT syndrome

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 50-57

  Hayashi, Kenshi ^a   Fujino, Noboru ^a   Ino, Hidekazu ^a   Uchiyama, Katsuharu ^a   Sakata, Kenji ^a   Konno, Tetsuo ^a   Masuta, Eiichi ^a   Funada, Akira ^a   Sakamoto, Yuichiro ^a   Tsubokawa, Toshinari ^a   Hodatsu, Akihiko ^a   Yasuda, Toshihiko ^b   Kanaya, Honin ^b   Kim, Min Young ^c   Kupershmidt, Sabina ^c   Higashida, Haruhiro ^a   Yamagishi, Masakazu ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Drugs; Electrophysiology; Hypokalemia; Ion channels; Long QT syndrome

Indexed keywords

COMPLEMENTARY DNA; DOFETILIDE; METOPROLOL; MEXILETINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL REGULATOR 1 PROTEIN; QUINIDINE; REGULATOR PROTEIN; SOTALOL; UNCLASSIFIED DRUG;

AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOKALEMIA; LONG QT SYNDROME; MALE; MUTANT; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; QT PROLONGATION; RISK FACTOR; SIMULATION; WILD TYPE; YEAST CELL;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CRICETULUS; DNA MUTATIONAL ANALYSIS; ELECTROPHYSIOLOGY; FEMALE; GENETIC COMPLEMENTATION TEST; GLUCOSYLTRANSFERASES; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 78650825624     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.007     Document Type: Article

References (30)

1. Roden D.M., Viswanathan P.C. Genetics of acquired long QT syndrome. J Clin Invest 2005, 115:2025-2032.
2. Donger C., Denjoy I., Berthet M., Neyroud N., Cruaud C., Bennaceur M., et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997, 96:2778-2781.
3. Makita N., Horie M., Nakamura T., Ai T., Sasaki K., Yokoi H., et al. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 2002, 106:1269-1274.
4. Napolitano C., Schwartz P.J., Brown A.M., Ronchetti E., Bianchi L., Pinnavaia A., et al. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias. J Cardiovasc Electrophysiol 2000, 11:691-696.
5. Hayashi K., Shimizu M., Ino H., Yamaguchi M., Terai H., Hoshi N., et al. Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG. Clin Sci (Lond) 2004, 107:175-182.
6. Paulussen A.D., Gilissen R.A., Armstrong M., Doevendans P.A., Verhasselt P., Smeets H.J., et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med 2004, 82:182-188.
7. Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H., Timothy K.W., et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97:175-187.
8. Roti E.C., Myers C.D., Ayers R.A., Boatman D.E., Delfosse S.A., Chan E.K., et al. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-a-go-go-Related Gene. J Biol Chem 2002, 277:47779-47785.
9. McDonald T.V., Yu Z., Ming Z., Palma E., Meyers M.B., Wang K.W., et al. A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature 1997, 388:289-292.
10. Kagan A., Melman Y.F., Krumerman A., McDonald T.V. 14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+channel activity. EMBO J 2002, 21:1889-1898.
11. Hoshi N., Takahashi H., Shahidullah M., Yokoyama S., Higashida H. KCR1, a membrane protein that facilitates functional expression of non-inactivating K+currents associates with rat EAG voltage-dependent K+channels. J Biol Chem 1998, 273:23080-23085.
12. Kupershmidt S., Yang I.C., Hayashi K., Wei J., Chanthaphaychith S., Petersen C.I., et al. The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. Faseb J 2003, 17:2263-2265.
13. Nakajima T., Hayashi K., Viswanathan P.C., Kim M.Y., Anghelescu M., Barksdale K.A., et al. HERG is protected from pharmacological block by alpha-1, 2-glucosyltransferase function. J Biol Chem 2007, 282:5506-5513.
14. Petersen C.I., McFarland T.R., Stepanovic S.Z., Yang P., Reiner D.J., Hayashi K., et al. In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia. Proc Natl Acad Sci U S A 2004, 101:11773-11778.
15. Kupershmidt S., Snyders D.J., Raes A., Roden D.M. A K+channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current. J Biol Chem 1998, 273:27231-27235.
16. Mumberg D., Muller R., Funk M. Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds. Gene 1995, 156:119-122.
17. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77:51-59.
18. Kupershmidt S., Yang T., Chanthaphaychith S., Wang Z., Towbin J.A., Roden D.M. Defective human Ether-a-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus. J Biol Chem 2002, 277:27442-27448.
19. Burda P., Aebi M. The ALG10 locus of Saccharomyces cerevisiae encodes the alpha-1, 2 glucosyltransferase of the endoplasmic reticulum: the terminal glucose of the lipid-linked oligosaccharide is required for efficient N-linked glycosylation. Glycobiology 1998, 8:455-462.
20. Roden D.M. Taking the "idio" out of "idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol 1998, 21:1029-1034.
21. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C., et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002, 105:1943-1948.
22. Itoh H., Sakaguchi T., Ding W.G., Watanabe E., Watanabe I., Nishio Y., et al. Latent genetic backgrounds and molecular pathogenesis in drug-induced long-QT syndrome. Circ Arrhythm Electrophysiol 2009, 2:511-523.
23. Sanguinetti M.C., Jiang C., Curran M.E., Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 1995, 81:299-307.
24. Sanguinetti M.C., Jurkiewicz N.K. Role of external Ca2+ and K+in gating of cardiac delayed rectifier K+currents. Pflugers Arch 1992, 420:180-186.
25. Choy A.M., Lang C.C., Chomsky D.M., Rayos G.H., Wilson J.R., Roden D.M. Normalization of acquired QT prolongation in humans by intravenous potassium. Circulation 1997, 96:2149-2154.
26. Compton S.J., Lux R.L., Ramsey M.R., Strelich K.R., Sanguinetti M.C., Green L.S., et al. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996, 94:1018-1022.
27. Yang T., Roden D.M. Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. Circulation 1996, 93:407-411.
28. Snyders D.J., Chaudhary A. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol 1996, 49:949-955.
29. Weerapura M., Nattel S., Chartier D., Caballero R., Hebert T.E. A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?. J Physiol 2002, 540:15-27.
30. Roden D.M. Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med 2006, 259:59-69.